You are here

Big pharma gets a boost as China speeds up new drug approvals

Data from overseas clinical trials can now be used for drug registrations in China

BT_20171010_PHARMA_3123931.jpg
Faster approvals could deliver a revenue boost to multinational pharmaceutical firms that are expanding in China.

Beijing

FOR decades, Chinese patients have struggled to gain access to cutting edge medicines thanks to bureaucratic delays that have hamstrung drug development. Now, a sweeping government overhaul of drug approvals is poised to change that.

Beijing on Sunday announced new rules...

sentifi.com

Market voices on: